FDA's review process under investigation

The Government Accountability Office is investigating whether the Food and Drug Administration's drug-review process cleared two blockbuster medications without sufficient proof of their safety or effectiveness. Sen. Charles Grassley suggested the investigation after recent studies showed the drugs may not lower the risk of heart attack and artery-clogging plaque, as assumed by millions of patients and doctors.